Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0399-2022Class II

SYNCHRON Systems Cholesterol (CHOL) Reagent, REF: 467825

Siemens Healthcare Diagnostics Inc. / initiated 2021-11-10 / Open, Classified / root cause: manufacturing process

Beckman Coulter Inc. began a recall of SYNCHRON Systems Cholesterol (CHOL) Reagent, REF: 467825 on . FDA classified it as Class II and gives the reason as "Cholesterol Reagent may fail with Out of Calibration Range Low (OCR Low) and/or Back to Back (B/B) errors. Low quality control recovery failures may be observed after passing calibration. Brown particulates in...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0399-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
SYNCHRON Systems Cholesterol (CHOL) Reagent, REF: 467825
Product code
CHH Enzymatic Esterase--Oxidase, Cholesterol
Reason for recall
Cholesterol Reagent may fail with Out of Calibration Range Low (OCR Low) and/or Back to Back (B/B) errors. Low quality control recovery failures may be observed after passing calibration. Brown particulates in compartment C of the reagent cartridge may be observed. Continued use may lead to, 1) failed QC and/or calibrations, 2) Erroneous low Cholesterol patient results.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On 11/10/21 recall notices were sent to customers. Customers with questions are encouraged to contact the Customer Support Center: http://www.beckmancoulter.com, 1-800-854-3633 in the United States and Canada. Customers were asked to take the following action: 1) Discontinue use of affected cholesterol reagent and follow the product replacement instructions. 2) Review the Safety Data Sheet (SDS) and discard according to your laboratory s Standard Operating Procedures and/or your local regulations. 3) Retrospective review is left to the discretion of the Laboratory Director. 4) Share this information with your laboratory staff and retain this notification as part of your laboratory Quality System documentation. If you have forwarded any of the affected product listed above to another laboratory, please provide them a copy of this letter. 5) Complete and return the Response Form. For customers in the United States, if you need replacement product, complete the Replacement Order Form.
Quantity in commerce
1433
Distribution
US Nationwide distribution in the states of Louisiana, Ohio, North Carolina, California, South Carolina, Oklahoma, Pennsylvania, New York, Florida, New Jersey, Wisconsin, Alabama, Texas, Georgia, Maine, North Dakota, Virginia, Kansas, Washington, New Mexico, Iowa ,Nebraska, Idaho, Michigan, Maryland, Arizona, Hawaii, Missouri, Oregon, Mississippi, Rhode Island, Alaska, Tennessee, Illinois, Delaware, Kentucky, Arkansas, West Virginia, Massachusetts. OUS: India, South Africa, Saudi Arabia, Canada, Lebanon, Singapore, Philippines, Thailand
Product codes and lots
Lot: M106450, UDI: 15099590575113

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0399-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0399-2022Class IIOngoingVoluntary: Firm initiated